PAYO vs ARDT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PAYO · Payoneer Global$7.15 ▼ 0.28%
ARDT · Ardent Health$17.30 ▲ 8.81%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PAYO +26.1%
- ARDT +26.6%
Head to head
| Metric | PAYO | ARDT |
|---|---|---|
| Price | $7.15 | $17.30 |
| Change today | ▼ 0.28% | ▲ 8.81% |
| Market cap | $2.44B | $2.44B |
| Return, 3 months | +0.8% | +56.4% |
| Return, year to date | +27.2% | +95.9% |
| Return, 1 year | +33.1% | +20.1% |
| P/E (TTM) | 51.1 | 16.8 |
| P/B | 3.7 | 1.7 |
| P/E percentile vs own 5y | 89th | 72nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +9.8% | -1.4% |
| Net profit growth (YoY) | -112.5% | -63.8% |
| Gross margin | – | 41.2% |
| Operating margin | -12.4% | 4.0% |
| Net margin | 5.8% | 1.2% |
| Return on equity | 7.1% | 6.0% |
| Analyst target vs. price | +3.5% | -29.0% |
| Analyst buy share | 0% | 56% |
| RSI (14) | 52 | 85 |
| 30-day volatility | 3.4% | 72.5% |
| Max drawdown, 1 year | -33.6% | -48.3% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ARDT is the largest of the group by market value.
- PAYO has returned the most over the past year.
- ARDT carries the lowest trailing P/E.
- PAYO is growing revenue fastest.
- PAYO keeps the most profit per dollar of sales.
- PAYO has been the calmest stock over the last 30 days.